Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
New Melocules

877399-52-5 Crizotinib

Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in anaplastic large cell lymphoma, neuroblastoma, and other advanced solid tumors in both adults and children.

877399-52-5 Crizotinib
Crizotinib 877399-52-5
Appearance:White powder
Cas No: 877399-52-5
EINECS:NA
Formula:C21H22Cl2FN5O
Molecular Weight:450.34
Melting Point:NA
Boiling Point:599.2°C
Flash Point: 316.5°C
Usage:antineoplastics
Testing Items
Standards:Enterprise
Appearance
White solid
Identification
should conform
Purity NLT98%

Disclaimer:Those products patented (877399-52-5 Crizotinib) are for lab analytical & research purposes only.